pharmaceuticals
Eli Lilly’s Breakthrough Weight Loss Drug Triumphs in Key Obesity Trial: What This Means for You
Eli Lilly has made exciting strides in the fight against obesity with its new drug, retatrutide. This medication just passed ... Read more
CVS Surpasses Expectations and Raises Forecast: Insurance Sector Shines in Latest Performance
CVS Health recently reported strong first-quarter earnings, surpassing what analysts expected. The company has seen improvements in its insurance arm, ... Read more
FDA Pulls Back on Studies Proving Safety of COVID and Shingles Vaccines: What You Need to Know
The FDA recently stopped the publication of several studies about the safety of Covid and shingles vaccines. This was confirmed ... Read more
Unlocking Healthcare Savings: What Netflix’s ‘Beef’ Reveals About Managing Your Own $5,000 Deductible
In the recent season of Netflix’s “Beef,” Ashley, a character played by Cailee Spaeny, ends up in the hospital due ... Read more
AstraZeneca Stock Slides as FDA Panel Rejects New Cancer Drug Proposal: What Does This Mean for Investors?
Shares of AstraZeneca dipped on Friday after U.S. regulators recommended against its new cancer drug. The FDA advisory committee voted ... Read more
Revolutionizing Clinical Trials: How the FDA is Accelerating Processes with AI Innovation
The FDA is taking exciting steps to improve clinical trials. Recently, they started reviewing data in real-time from trials run ... Read more
Erasca Unveils Promising Preliminary Results for Innovative Pancreatic and Lung Cancer Therapy
Erasca recently announced exciting results about its RAS-targeting pill, ERAS-0015. In tests, the drug helped shrink tumors in 40% of ... Read more
Intellia Therapeutics’ CRISPR Breakthrough: Pivotal Trial Confirms Successful Treatment Results
Intellia Therapeutics is making waves in the world of gene editing. Their new treatment for hereditary angioedema, a condition that ... Read more
UnitedHealth Surpasses Quarterly Expectations and Raises Profit Outlook Amid Rising Medical Costs
UnitedHealth Group recently announced impressive first-quarter earnings, surpassing expectations and raising its profit outlook for 2026. The company, which is ... Read more
How Eli Lilly’s $3.25 Billion Acquisition of Kelonia Therapeutics Marks a Turning Point in the Startup’s Challenging Journey
Eli Lilly has announced a significant move: they are acquiring Kelonia Therapeutics for $3.25 billion. This small biotech firm specializes ... Read more
